الصفحة الرئيسية>>Signaling Pathways>> PROTAC>>Azido-PEG2-C2-amine

Azido-PEG2-C2-amine

رقم الكتالوجGC60067

Azido-PEG2-C2-amine (N3-PEG2-CH2CH2NH2) عبارة عن رابط PROTAC قائم على PEG يمكن استخدامه في تركيب PROTACsAzido-PEG2-C2-amine هو أيضًا رابط PEG ADC مكون من وحدتين غير قابل للانشقاق يستخدم في تخليق اتحادات الأجسام المضادة والأدوية (ADCs)

Products are for research use only. Not for human use. We do not sell to patients.

Azido-PEG2-C2-amine التركيب الكيميائي

Cas No.: 166388-57-4

الحجم السعر المخزون الكميّة
250mg
59٫00
متوفر
500mg
77٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Azido-PEG2-C2-amine (N3-PEG2-CH2CH2NH2) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Azido-PEG2-C2-amine is also a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[2].

PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1].ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[2].

[1]. Su S, et al. Potent and Preferential Degradation of CDK6 via Proteolysis Targeting Chimera Degraders. J Med Chem. 2019 Aug 22;62(16):7575-7582. [2]. Tominari, Yusuk , et al. Heterocyclic compound. WO2020027225A1.

مراجعات

Review for Azido-PEG2-C2-amine

Average Rating: 5 ★★★★★ (Based on Reviews and 33 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Azido-PEG2-C2-amine

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.